January 2020
1. GULATI S, Desai J, Palackdharry SM, Morris JC, et al
   Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.
   Cancer. 2020;126:354-362.
   

   >> Share

   
   August 2019
2. AMENABAR JM, Torres-Pereira CC, Tang KD, Punyadeera C, et al
   Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
   Cancer. 2019 Aug 7. doi: 10.1002/cncr.32435.
   

   >> Share

   
   April 2019
3. PAL SK, Forero-Torres A, Thompson JA, Morris JC, et al
   A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
   Cancer. 2019;125:1124-1132.
   

   >> Share

   
   October 2018
4. DEEG HJ
   More Than One Angle to Target Aplastic Anemia?
   Cancer. 2018 Oct 11. doi: 10.1002/cncr.31656.
   

   >> Share

   
   
5. ASSI R, Garcia-Manero G, Ravandi F, Borthakur G, et al
   Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
   Cancer. 2018 Oct 11. doi: 10.1002/cncr.31658.
   

   >> Share

   
   July 2017
6. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
   Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
   Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
   

   >> Share

   
   May 2017
7. LIN CJ, Vader JM, Slade M, DiPersio JF, et al
   Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
   Cancer. 2017;123:1800-1809.
   

   >> Share

   
   
8. STAHL M, Zeidan AM
   Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.
   Cancer. 2017;123:1703-1713.
   

   >> Share

   
   March 2017
9. YUCEL OK, Saliba RM, Rondon G, Ahmed S, et al
   Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogenic stem cell transplantation using reduced intensity conditioning.
   Cancer. 2017 Mar 21. doi: 10.1002/cncr.30632.
   

   >> Share

   
   January 2017
10. MANCUSO A
    Management of hepatocellular carcinoma in thalassemia and importance of the human factor.
    Cancer. 2017 Jan 13. doi: 10.1002/cncr.30551.
    

    >> Share

    
    
11. MOUKHADDER HM, Halawi R, Cappellini MD, Taher AT, et al
    Reply to Management of hepatocellular carcinoma in thalassemia and importance of the human factor.
    Cancer. 2017 Jan 13. doi: 10.1002/cncr.30550.
    

    >> Share

    
    December 2016
12. MOUKHADDER HM, Halawi R, Cappellini MD, Taher AT, et al
    Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30462.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share